Chemours Company (The) (CC)
NYSE: CC · Chemicals & Allied Products · Wilmington, DE
Our rating: Cautious
Cautious reaffirmed at $21.77, moderate conviction, June 18, 2026.
Breaks if: The Cautious call is wrong if Chemours generates free cash flow above $120M in any single fiscal half-year in the next twelve months, or if reported net income turns positive for a full fiscal year — either outcome would indicate the loss is non-recurring and the cash engine is genuinely rebuilding.
Key figures
| Market value | $1.6B |
|---|---|
| Revenue, last 12 months | $5.8B |
| Net income, last 12 months | −$154M |
| Free cash flow, last 12 months | $211M |
| Price to earnings | n/a |
| Free cash flow yield | 12.9% |
| Dividend yield | 3.2% |
| Operating margin | n/a |
| Return on equity | −71.8% |
| Beta to the S&P 500 | 1.78 |
| Volatility, annualized | 60.2% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $1.5B | 3.0% | $1.29 | $98M |
| June 30, 2026 | $1.6B | −1.5% | $-1.81 | $114M |
| March 31, 2026 | $1.4B | 1.0% | $-0.19 | −$93M |
| December 31, 2025 | $1.3B | −2.2% | $-0.31 | $92M |
| September 30, 2025 | $1.5B | −0.9% | $0.31 | $105M |
| June 30, 2025 | $1.6B | 3.9% | $-2.53 | $50M |
| March 31, 2025 | $1.4B | 0.4% | $-0.03 | −$196M |
| December 31, 2024 | $1.4B | −0.7% | $-0.08 | $29M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $1.33B: Claude 72%, Gemini 85%, Mistral 85%
- Diluted earnings per share are above zero: Claude 55%, Gemini 30%, Mistral 38%
- Free cash flow for the quarter is at least $0.09B: Claude 60%, Gemini 75%, Mistral 55%
- Backlog at the end of the quarter is at least $0.10B: Claude 55%, Gemini 15%, Mistral 35%
8 ledger entries and 76 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.